dc.contributor.author | Perry, Meghan R | |
dc.contributor.author | Prajapati, Vijay K | |
dc.contributor.author | Menten, Joris | |
dc.contributor.author | Raab, Andrea | |
dc.contributor.author | Feldmann, Joerg | |
dc.contributor.author | Chakraborti, Dipankar | |
dc.contributor.author | Sundar, Shyam | |
dc.contributor.author | Fairlamb, Alan H | |
dc.contributor.author | Boelaert, Marleen | |
dc.contributor.author | Picado, Albert | |
dc.date.accessioned | 2016-07-27T11:55:03Z | |
dc.date.available | 2016-07-27T11:55:03Z | |
dc.date.issued | 2015-03-02 | |
dc.identifier.citation | Perry , M R , Prajapati , V K , Menten , J , Raab , A , Feldmann , J , Chakraborti , D , Sundar , S , Fairlamb , A H , Boelaert , M & Picado , A 2015 , ' Arsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India : a retrospective cohort study ' , PLoS Neglected Tropical Diseases , vol. 9 , no. 3 , e0003518 . https://doi.org/10.1371/journal.pntd.0003518 | en |
dc.identifier.issn | 1935-2735 | |
dc.identifier.other | PURE: 69482368 | |
dc.identifier.other | PURE UUID: 435c9c64-4810-4cc6-8159-6190e6550fe0 | |
dc.identifier.other | PubMed: 25730310 | |
dc.identifier.other | Scopus: 84928812685 | |
dc.identifier.other | ORCID: /0000-0002-0524-8254/work/31459816 | |
dc.identifier.other | ORCID: /0000-0003-2058-0105/work/72631117 | |
dc.identifier.uri | http://hdl.handle.net/2164/6263 | |
dc.description | Funding: This work was supported by a Clinical PhD Fellowship to MRP (090665) and a Principal Research Fellowship to AHF (079838) from the Wellcome Trust (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. | en |
dc.language.iso | eng | |
dc.relation.ispartof | PLoS Neglected Tropical Diseases | en |
dc.rights | Copyright: © 2015 Perry et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. https://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | Adolescent | en |
dc.subject | Adult | en |
dc.subject | Antimony Sodium Gluconate | en |
dc.subject | Antiprotozoal Agents | en |
dc.subject | Arsenic | en |
dc.subject | Child | en |
dc.subject | Child, Preschool | en |
dc.subject | Cohort Studies | en |
dc.subject | Drug Resistance | en |
dc.subject | Female | en |
dc.subject | Humans | en |
dc.subject | India | en |
dc.subject | Leishmaniasis, Visceral | en |
dc.subject | Logistic Models | en |
dc.subject | Male | en |
dc.subject | Middle Aged | en |
dc.subject | Retrospective Studies | en |
dc.subject | Treatment Failure | en |
dc.subject | QD Chemistry | en |
dc.subject | Wellcome Trust | en |
dc.subject | 090665 | en |
dc.subject | 079838 | en |
dc.subject.lcc | QD | en |
dc.title | Arsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India : a retrospective cohort study | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Chemistry | en |
dc.contributor.institution | University of Aberdeen.Energy | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1371/journal.pntd.0003518 | |